In a complete agreement with this view, we found DEA to act as an apoptosis-stimulating factor for the melanoma cells presumably via upregulation of p53 and Bax, and downregulation of Bcl-2 (Figs 3 and 4). The gene discussed is BCL2; the disease is melanoma.